Insulin Pathways for Therapeutic Intervention
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 October 2020) | Viewed by 19906
Special Issue Editor
Interests: neurobiology of insulin peptides; blood–brain barrier; neurodegeneration; energy homeostasis; regulation of mood and cognition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pleiotropy of insulin and its related peptides (ILPs), particularly IGFs, makes ILP pathways of great therapeutic potential, as an ever increasing number of pathologies are being recognized to involve deficient ILP activity. On top of the classical endocrine-related maladies, where the role of ILPs is well established, such as metabolic and growth disorders associated in turn to cardiovascular, bone, and renal disturbances, compelling evidence indicates that ILPs are involved in brain diseases, circadian disruption, and even tumor pathology. Together with the relatively recent advent of geroscience as a target of medical intervention, and given the prominent role of ILPs in normal and pathological aging, we may consider that pathways involved in ILP signaling constitute a major source of druggable targets as they encompass all the main types of human diseases. A better understanding of inter- and intracellular ILP communication as well as their molecular mediators is therefore of paramount medical importance.
Prof. Dr. Ignacio Torres Aleman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- insulin
- insulin-like peptides
- human diseases
- therapy
- drug targets
- signaling pathways
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
